|
ADRB2 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.86660000035222E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.4841000063941E-09 |
| Normal-vs-Stage2 |
4.69719999995899E-06 |
| Normal-vs-Stage3 |
1.580470E-03 |
| Normal-vs-Stage4 |
8.595700E-03 |
| Stage1-vs-Stage2 |
3.889200E-01 |
| Stage1-vs-Stage3 |
1.238800E-01 |
| Stage1-vs-Stage4 |
3.863400E-01 |
| Stage2-vs-Stage3 |
1.141570E-01 |
| Stage2-vs-Stage4 |
2.289400E-01 |
| Stage3-vs-Stage4 |
8.552800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74441999999386E-05 |
| Normal-vs-AfricanAmerican |
3.766400E-02 |
| Normal-vs-Asian |
2.632200E-04 |
| Caucasian-vs-AfricanAmerican |
9.532000E-01 |
| Caucasian-vs-Asian |
6.823000E-01 |
| AfricanAmerican-vs-Asian |
8.696400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.1720999999465E-06 |
| Normal-vs-Female |
3.53019999999038E-06 |
| Male-vs-Female |
6.832200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31629999625227E-08 |
| Normal-vs-Age(41-60Yrs) |
6.66229999946033E-07 |
| Normal-vs-Age(61-80Yrs) |
2.169200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.705000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.691800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.302600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.148250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.777000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.047900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.216000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.605600E-01 |
| Classical-VS-Follicular |
9.98989999945188E-07 |
| Classical-VS-Other |
3.831200E-01 |
| Classical-VS-Normal |
3.59490000000351E-05 |
| Tall-VS-Follicular |
2.014000E-02 |
| Tall-VS-Other |
4.857000E-01 |
| Tall-VS-Normal |
3.357800E-04 |
| Follicular-VS-Other |
6.529200E-01 |
| Follicular-VS-Normal |
1.06039621527998E-11 |
| Other-VS-Normal |
6.237300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.87700000489721E-08 |
| Normal-vs-N1 |
7.774900E-04 |
| N0-vs-N1 |
5.856800E-01 |
|
|
